CORNERSTONE THERAPEUTICS INC 4
4 · CORNERSTONE THERAPEUTICS INC · Filed Feb 4, 2014
Insider Transaction Report
Form 4
MCEWAN ALASTAIR STUART
Director
Transactions
- Disposition to Issuer
Common Stock
2014-02-03$9.50/sh−272,241$2,586,290→ 0 total - Disposition to Issuer
Common Stock
2014-02-03$9.50/sh−44,172$419,634→ 0 total
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Chiesi Farmaceutici S.p.A., Chiesi U.S. Corporation, and Cornerstone Therapeutics Inc., dated as of September 15, 2013, on the effective date of the merger contemplated by the Agreement (the "Merger"), each of these shares of common stock were automatically converted into the right to receive $9.50, without interest.
- [F2]Represents shares of restricted stock. Pursuant to the Merger, each restricted stock award outstanding at the effective time of the Merger was converted into the right to receive an amount in cash equal to the product of (i) $9.50 and (ii) the number of shares of Cornerstone Therapeutics Inc. common stock subject to such award.